Additionally, the need to effectively treat severe human ovarian diseases such as cancer, premature ovarian failure (POF), and polycystic ovary syndrome (PCOS) has intensified studies aimed at uncovering the impact of Akt signaling. This evidence concerns the gene AKT1 and cancer.